Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Ulander

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|December 12, 2012
Discovery of agonists of cannabinoid receptor 1 with restricted central nervous system penetration aimed for treatment of gastroesophageal reflux diseaseAlleyn T Plowright, Karolina Nilsson, Madeleine Antonsson, et al.
Journal of Medicinal Chemistry|April 2, 2019
Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery DiseaseMalin Lemurell, Johan Ulander, Hans Emtenäs, et al.
Journal of Medicinal Chemistry|March 15, 2019
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery DiseaseDaniel Pettersen, Johan Broddefalk, Hans Emtenäs, et al.
Journal of Medicinal Chemistry|December 6, 2014
Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseasesMalin Lemurell, Johan Ulander, Susanne Winiwarter, et al.
ACS Nano|March 18, 2026
The Impact of Polyethylene Glycol Lipid Anchors on the Physicochemical Properties, Protein Corona, Function, and Biodistribution of Lipid NanoparticlesChuan-En Lu, Kai Liu, Audrey Gallud, et al.
Journal of Medicinal Chemistry|March 19, 2024
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart FailureKenneth L Granberg, Shigeki Sakamaki, Niklas Larsson, et al.
Journal of Cheminformatics|December 23, 2017
11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015Uli Fechner, Chris de Graaf, Andrew E Torda, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|December 12, 2012
Discovery of agonists of cannabinoid receptor 1 with restricted central nervous system penetration aimed for treatment of gastroesophageal reflux diseaseAlleyn T Plowright, Karolina Nilsson, Madeleine Antonsson, et al.
Journal of Medicinal Chemistry|April 2, 2019
Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery DiseaseMalin Lemurell, Johan Ulander, Hans Emtenäs, et al.
Journal of Medicinal Chemistry|March 15, 2019
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery DiseaseDaniel Pettersen, Johan Broddefalk, Hans Emtenäs, et al.
Journal of Medicinal Chemistry|December 6, 2014
Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseasesMalin Lemurell, Johan Ulander, Susanne Winiwarter, et al.
ACS Nano|March 18, 2026
The Impact of Polyethylene Glycol Lipid Anchors on the Physicochemical Properties, Protein Corona, Function, and Biodistribution of Lipid NanoparticlesChuan-En Lu, Kai Liu, Audrey Gallud, et al.
Journal of Medicinal Chemistry|March 19, 2024
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart FailureKenneth L Granberg, Shigeki Sakamaki, Niklas Larsson, et al.
Journal of Cheminformatics|December 23, 2017
11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015Uli Fechner, Chris de Graaf, Andrew E Torda, et al.
Pageof 3